about
Priority setting for new technologies in medicine: a transdisciplinary study.Why bioethicists have nothing useful to say about health care rationing.Rationing: a transatlantic perspective.Bioethics in developing countries: ethics of scarcity and sacrifice.Ethical dilemmas for general practitioners under the UK new contract.Ethics of queuing for coronary artery bypass grafting in CanadaHow many lives is equity worth? A proposal for equity adjusted years of life saved.Economic evaluations of health technologies in Dutch healthcare decision-making: a qualitative study of the current and potential use, barriers, and facilitatorsThe missing link in preconceptional care: the role of comparative effectiveness researchA noticeable difference? Productivity costs related to paid and unpaid work in economic evaluations on expensive drugs.Do productivity costs matter?: the impact of including productivity costs on the incremental costs of interventions targeted at depressive disorders.Productivity costs in economic evaluations: past, present, future.The cost of premature cancer-related mortality: a review and assessment of the evidence.Productivity Losses Associated with Head and Neck Cancer Using the Human Capital and Friction Cost Approaches.Hidden costs: The ethics of cost-effectiveness analyses for health interventions in resource-limited settings.Who is entitled to long-term health care? Emerging policy and moral debate.Predicting productivity based on EQ-5D: an explorative study.The right perspective on responsibility for ill health.The use of leverage in community mental health: ethical guidance for practitioners.Understanding Harris' understanding of CEA: is cost effective resource allocation undone?Allocating organ transplant services: what can be learned from the United States experience?Enhancing the Clinical Value of Medical Laboratory Testing.Rationing in health systems: A critical review.A cost-utility analysis of medium vs. high-fidelity human patient simulation manikins in nursing education.Values and evaluation in health care.
P2860
Q24799303-7652C1B0-D878-4308-BF0F-73DDDB851E0DQ30423346-C0D8D45E-EF6B-4B77-8656-7174994B3A5FQ34055170-CE45273F-F13F-44B0-966A-5174520DBC56Q34383706-09153022-F491-4A9B-8480-7FD5C8B31C10Q34383714-6E73B37C-B5C4-4DFF-A82F-0B3CF953CEAEQ34411058-7F52C499-14D1-4469-BF94-FB3E9659CAB8Q35558069-0ADC8CD7-35FA-46C9-B8EE-FF4F94665466Q36261736-A8FB8050-9893-4533-A2DD-A19794FF75ECQ36746558-1BB21DBF-F69B-4FF0-A86E-106646F3A1F7Q36814377-C3CA796A-9EDC-4786-87F4-0451FDE2C117Q37872289-EE8D4788-7852-4AC7-AE35-8F6A3AB391BEQ38101894-E55D27AA-DBA1-4582-8134-AF0107BE0843Q38205587-CD6DAAD4-609D-42B5-9E35-2F36DF43F956Q39037810-2777177C-69D2-46E4-9CAA-37FE11A1ECB3Q40689362-7DBEA26C-0360-43C1-BFB4-D4D24871944BQ41724997-09A43CBE-0C9A-4E1F-A5E7-CB25FC004F5BQ43455325-79A4060F-F016-40B7-B819-37BAEE125B70Q46715950-694DAEFC-59B6-41FE-9FD7-C404AAE997B3Q48086667-A20AED61-D8BE-406E-AF65-6E54A4179AB9Q48302738-D702C1C0-1390-498F-84B3-5BCB145B1581Q48659403-9CA99CED-38CC-4FCE-B616-1C47F9BA5C30Q49552078-1D01F794-6608-45C0-A210-DC75D2E6C3DDQ49995340-765153EB-EEFA-4036-9CC6-70BA8D4290E9Q51854101-6EC22C35-6303-4CCB-BC7B-5B8A315C1AC3Q53449129-1A0B86D8-B2B6-432B-9CE9-0ECD1421A351
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մարտին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Cost-effectiveness analysis: is it ethical?
@ast
Cost-effectiveness analysis: is it ethical?
@en
Cost-effectiveness analysis: is it ethical?
@nl
type
label
Cost-effectiveness analysis: is it ethical?
@ast
Cost-effectiveness analysis: is it ethical?
@en
Cost-effectiveness analysis: is it ethical?
@nl
prefLabel
Cost-effectiveness analysis: is it ethical?
@ast
Cost-effectiveness analysis: is it ethical?
@en
Cost-effectiveness analysis: is it ethical?
@nl
P356
P1476
Cost-effectiveness analysis: is it ethical?
@en
P2093
Williams A
P356
10.1136/JME.18.1.7
P577
1992-03-01T00:00:00Z